Published in Vaccine Weekly, April 18th, 2001
Oral vaccination is highly desirable in terms of cost, safety, and appeal, but until now, oral delivery has suffered from low bioavailability and a lack of uptake in intestinal lymph tissues.
I.M. van der Lubben and colleagues proposed that chitosan microparticles offer a unique vehicle for vaccine delivery because they are small enough to be absorbed by Peyer's patches in mice and bioavailable enough to release...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2001-04-18)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.